Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Is Time to Reach EDSS 6.0 Faster in Patients with Late-Onset versus Young-Onset Multiple Sclerosis?
T cell cytokine signatures: Biomarkers in pediatric multiple sclerosis.
Disability Progression in Multiple Sclerosis Is Affected by the Emergence of Comorbid Arterial Hypertension.
Ghrelin and adipose-derived mesenchymal stromal cells improve nerve regeneration in a rat model of epsilon-caprolactone conduit reconstruction.
The immunogenetics of multiple sclerosis. The frequency of HLA-alleles class 1 and 2 is lower in Southern Brazil than in the European population.
"Gadolinium-Phobia:" Not a Helpful "Criterion" for Indication for Gadolinium-based Contrast Agent Administration in Multiple Sclerosis.
Extracellular Vesicles from Vascular Endothelial Cells Promote Survival, Proliferation and Motility of Oligodendrocyte Precursor Cells.
MicroRNA-155 enhances T cell trafficking and antiviral effector function in a model of coronavirus-induced neurologic disease.
The Dress: Transforming a web viral event into a scientific survey.
Neurofilament light in CSF and serum is a sensitive marker for axonal white matter injury in MS.
Activated CD4+ and CD8+ T Cell Proportions in Multiple Sclerosis Patients.
Whole brain MP2RAGE-based mapping of the longitudinal relaxation time at 9.4T.
[Recurrent encephalitis following annual influenza vaccine. Case report].
Focal white matter lesions drive grey matter inflammation and synapse loss.
A telomere-lipid-immunity axis linking viral integration to autoimmune disease risk.
A novel clip-based nerve compression model with high stability and reproducibility for the study of chronic nerve injury associated with neuropathic pain.
Luteolin as a dietary flavonoid for brain health: modulating neuroinflammation and cognitive decline in neurodegenerative disorders.
Sleep disturbances and their clinical and psychiatric correlates in pediatric-onset multiple sclerosis.
Examining the Impact of Perceived and Objective Cognitive Function on Social Participation in Individuals with Multiple Sclerosis.
Development and expert refinement of a stratified framework for progression independent of relapse activity (PIRA) in multiple sclerosis.
The central role of mitochondrial dysfunction in neurodegeneration: implications for therapy.
Indirect Costs Related to Productivity Loss, Work-Related Quality of Life, and Resource Utilization in Workers with Multiple Sclerosis.
c-FLIP as a master regulator of immune homeostasis and disease mechanisms.
Astrocytopathy in Wernicke Encephalopathy and Neuromyelitis Optica Spectrum Disorder. Pathogenic Differences With Occasional Clinical and Neuroimaging Overlap. A Review.
Pages
« first
‹ previous
…
810
811
812
813
814
815
816
817
818
…
next ›
last »